GSK announces positive Phase III efficacy and safety data for daprodustat in patients with anaemia due to chronic kidney disease
Provider: View Press Release Type: Link Title: GSK announces positive Phase III efficacy and safety data for daprodustat in patients with anaemia due to chronic kidney disease | GSK Description: Pivotal trials in non-dialysis and dialysis populations published simultaneously in the New England Journal of Medicine
ViiV Healthcare presents positive interim data showing Vocabria (cabotegravir) and Rekambys (rilpivirine) can be implemented successfully in a variety of European healthcare settings
ViiV Healthcare presents positive interim data showing Vocabria (cabotegravir) and Rekambys (rilpivirine) can be implemented successfully in a variety of European healthcare settings
Provider: View Press Release Type: Link Title: ViiV Healthcare presents positive interim data showing Vocabria (cabotegravir) and Rekambys (rilpivirine) can be implemented successfully in a variety of European healthcare settings | GSK Description: The CARISEL study showed most people living with HIV who started treatment felt positive about the long-acting regimen
GSK announces Dr Harry (Hal) C. Dietz MD to join the Board as Non-Executive Director
Provider: View Press Release Type: Link Title: GSK announces Dr Harry (Hal) C. Dietz MD to join the Board as Non-Executive Director | GSK Description: Appointment further strengthens Board scientific capabilities, including in genetics which is central to GSK’s R&D approach
GSK Consumer Healthcare solidifies commitment to pharmacists with 3-year Pharmacist Support Programme
Provider: View Press Release Type: Link Title: GSK Consumer Healthcare solidifies commitment to pharmacists with 3-year Pharmacist Support Programme | GSK Description: Helping global pharmacy teams play a critical role in improving public health in the age of self-care.
US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes unanimously to recommend Shingrix for immunocompromised adults aged 19 and up
US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes unanimously to recommend Shingrix for immunocompromised adults aged 19 and up
Provider: View Press Release Type: Link Title: US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes unanimously to recommend Shingrix for immunocompromised adults aged 19 and up | GSK Description: US CDC and Prevention’s Advisory Committee votes unanimously to recommend Shingrix for immunocompromised adults aged 19 & up
